Literature DB >> 22070770

Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.

Tze Kin Lau1, Fang Chen, Xiaoyu Pan, Ritsuko K Pooh, Fuman Jiang, Yihan Li, Hui Jiang, Xuchao Li, Shengpei Chen, Xiuqing Zhang.   

Abstract

OBJECTIVE: To develop a new bioinformatic method in the noninvasive prenatal identification of common fetal aneuploidies using massively parallel sequencing on maternal plasma.
METHODS: Massively parallel sequencing was performed on plasma DNA samples from 108 pregnant women (median gestation: 12(+5) week) immediately before chorionic villus sampling (CVS) or amniocentesis. Data were analysed using a novel z-score method with internal reference chromosome. The diagnostic accuracies of the fetal karyotyping status were compared against two previously reported z-score methods--one without adjustment and the other with GC correction.
RESULTS: A total of 32 cases with fetal aneuploidy were confirmed by conventional karyotyping, including 11 cases of Trisomy 21, 10 cases of Trisomy 18, 2 cases of Trisomy 13, 8 cases of Turner syndrome (45, XO) and one case of Klinefelter syndrome (47, XXY). Using the z-score method without reference adjustment, the detection rate for Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, and Klinefelter's syndrome is 100%, 40%, 0%, 88% and 0% respectively. Using the z-score method with GC correction, the detection rate increased to 100% for Trisomy 21, 90% for Trisomy 18, 100% for Trisomy 13. By using the z-score method with internal reference, the detection rate increased to 100% for all aneuploidies. The false positive rate was 0% for all three methods.
CONCLUSION: This massively parallel sequencing-based approach, combined with the improved z-score test methodology, enables the prenatal diagnosis of most common aneuploidies with a high degree of accuracy, even in the first trimester of pregnancy.

Entities:  

Mesh:

Year:  2012        PMID: 22070770     DOI: 10.3109/14767058.2011.635730

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  28 in total

Review 1.  Next-generation molecular diagnosis: single-cell sequencing from bench to bedside.

Authors:  Wanjun Zhu; Xiao-Yan Zhang; Sadie L Marjani; Jialing Zhang; Wengeng Zhang; Shixiu Wu; Xinghua Pan
Journal:  Cell Mol Life Sci       Date:  2016-10-13       Impact factor: 9.261

2.  Chinese genomics giant BGI plots commercial path.

Authors:  David Cyranoski
Journal:  Nat Biotechnol       Date:  2012-12       Impact factor: 54.908

Review 3.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

Review 4.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013

5.  Non-invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta-analysis of diagnostic test accuracy studies.

Authors:  Bounhome Soukkhaphone; Carmen Lindsay; Sylvie Langlois; Julian Little; Francois Rousseau; Daniel Reinharz
Journal:  Mol Genet Genomic Med       Date:  2021-03-23       Impact factor: 2.183

6.  Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

Authors:  Tze Kin Lau; Mei Ki Chan; Pui Shan Salome Lo; Hon Yee Connie Chan; Wai Sze Kim Chan; Tik Yee Koo; Hoi Yan Joyce Ng; Ritsuko K Pooh
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-28

7.  The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy.

Authors:  Herb Brar; Eric Wang; Craig Struble; Thomas J Musci; Mary E Norton
Journal:  J Matern Fetal Neonatal Med       Date:  2012-09-12

8.  Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.

Authors:  Fuman Jiang; Jinghui Ren; Fang Chen; Yuqiu Zhou; Jiansheng Xie; Shan Dan; Yue Su; Jianhong Xie; Baomin Yin; Wen Su; Huakun Zhang; Wei Wang; Xianghua Chai; Linhua Lin; Hui Guo; Qiyun Li; Peipei Li; Yuying Yuan; Xiaoyu Pan; Yihan Li; Lifu Liu; Huifei Chen; Zhaoling Xuan; Shengpei Chen; Chunlei Zhang; Hongyun Zhang; Zhongming Tian; Zhengyu Zhang; Hui Jiang; Lijian Zhao; Weimou Zheng; Songgang Li; Yingrui Li; Jun Wang; Jian Wang; Xiuqing Zhang
Journal:  BMC Med Genomics       Date:  2012-12-01       Impact factor: 3.063

9.  Noninvasive prenatal detection for pathogenic CNVs: the application in α-thalassemia.

Authors:  Huijuan Ge; Xuan Huang; Xuchao Li; Shengpei Chen; Jing Zheng; Haojun Jiang; Chunlei Zhang; Xiaoyu Pan; Jing Guo; Fang Chen; Ning Chen; Qun Fang; Hui Jiang; Wei Wang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Effective noninvasive zygosity determination by maternal plasma target region sequencing.

Authors:  Jing Zheng; Chenming Xu; Jing Guo; Yuan Wei; Huijuan Ge; Xuchao Li; Chunlei Zhang; Haojun Jiang; Ling Pan; Weiping Tang; Weiwei Xie; Hongyun Zhang; Yangyu Zhao; Fuman Jiang; Shengpei Chen; Wei Wang; Xun Xu; Fang Chen; Hefeng Huang; Hui Jiang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.